Error message

Deprecated function: The each() function is deprecated. This message will be suppressed on further calls in theme_biblio_custom() (line 367 of /home/phcogcommn/phcogcommn.org/sites/all/modules/biblio/includes/biblio_theme.inc).

Medicinal Plant Images

groupview

Abstract
Pharmacognosy Communications,2021,11,2,143-144.
Published:April 2021
Type:Medicinal Plant Images

Medicinal Plant Images

Dr. Ian Edwin Cock1,2

1Environmental Futures Research Institute, Nathan Campus, Griffith University, 170 Kessels Rd, Nathan, Brisbane, Queensland 4111, AUSTRALIA.

2School of Natural Sciences, Nathan Campus, Griffith University, 170 Kessels Rd, Nathan, Brisbane, Queensland 4111, AUSTRALIA.

Abstract:

Swainsona formosa (G.Don) Joy Thomps. (family Fabaceae; synonyms Clianthus formosus (G.Don) Ford & Vickery, Clianthus dampieri Lindl., Clianthus oxleyi A.Cunn. ex Lindl.; commonly known as Sturt’s desert pea) is a low growing or prostrate legume which is endemic to arid inland regions of the Australian continent. Several Swainsona spp. were used by Australian Aborigines as traditional medicines.[1,2] Swainsona galegifolia (Andrews) R.Br. and Swainsona pterostylis (DC.) Bakh.f. were considered particularly useful as antiseptics and as bacteriocide chemotherapies against a broad spectrum of bacterial pathogens.[1,2] A recent study has also reported bacterial growth inhibitory activity for S. formosa leaf extracts against wide range of gram positive and gram negative bacteria[3] A defining phytochemical characteristic of many Swainsona spp. is the presence of the indolizidine alkaloid phytotoxin swainsonine.[4] Swainsonine has been associated with livestock intoxication via inhibition of the enzymes α-mannosidase and mannosidase II, which are required for processing and maturation of N-linked oligosaccharides of newly synthesised glycoproteins. To date, most interest in the therapeutic properties of swainsonine have focussed on its potential as a cancer chemotherapeutic drug via a reduction of tumour cell metastatis, decreased proliferation and enhanced cellular immune responses.[5] Photograph was taken by Dr Ian Cock. Read more....

Cite This Article

Vancouver Style :: Cock IEdwin. Medicinal Plant Images. Pharmacognosy Communications. 2021;11(2):143-144.  (1.26 MB)
MLA Style: Cock IEdwin. Medicinal Plant Images. Pharmacognosy Communications. 2021;11(2):143-144.  (1.26 MB)
CSE Style: Cock IEdwin. Medicinal Plant Images. Pharmacognosy Communications. 2021;11(2):143-144.  (1.26 MB)
APA Style: Cock IEdwin. Medicinal Plant Images. Pharmacognosy Communications. 2021;11(2):143-144.  (1.26 MB)

Founded:  In 2004, as the PHCOG.NET – a non-profit private organization dedicated to Natural Products Research leading to develop promising drugs. Our main mission is to make information on herbal drug research readily available in different formats to suit the individual needs.

Pharmacognosy Communications [Phcog Commn.] is a new quarterly journal published by Phcog.Net. It is a peer reviewed journal aiming to publish high quality original research articles, methods, techniques and evaluation reports, critical reviews, short communications, commentaries and editorials of all aspects of medicinal plant research. The journal is aimed at a broad readership, publishing articles on all aspects of pharmacognosy, and related fields. The journal aims to increase understanding of pharmacognosy as well as to direct and foster further research through the dissemination of scientific information by the  publication of manuscripts. The submission of original contributions in all areas of pharmacognosy are welcome.

The journal aims to cater the latest outstanding developments in the field of pharmacognosy and natural products and drug design covering but not limited to the following topics:

  • Pharmacognosy and pharmacognistic investigations
  • Research based ethnopharmacological evaluations
  • Biological evaluation of crude extracts, essential oils and pure isolates
  • Natural product discovery and evaluation
  • Mechanistic studies
  • Method and technique development and evaluation
  • Isolation, identification and structural elucidation of natural products
  • Synthesis and transformation studies

Distinctions:  The most widely read, cited, and known Pharmacognosy Communications and website is well browsed with all the articles published. More than 20,000 readers in nearly every country in the world each month

Aim and Scope | Editorial Board | Indexed & Abstracted | Instruction to Authors | Manuscript Submission & Charges

Subjects Covered : Natural Products, Pharmacognosy, Phytochemistry, Marine Pharmacognosy and Zoo Pharmacognosy
ISSN :2249-0159 (Print) ; 2249-0167 (Online) Frequency : Quarterly Rapid at a time publication (4 issues/year)

Indexed and Abstracted in : Chemical Abstracts, Excerpta Medica / EMBASE, Google Scholar, CABI Full Text, Ulrich’s International Periodical Directory, ProQuest, Journalseek & Genamics, PhcogBase, EBSCOHost, Academic Search Complete, Open J-Gate, SciACCESS.
Rapid publication: Average time from submission to first decision is 30 days and from acceptance to In Press online  publication is 45 days.
Open Access Journal: Phcog Commn. is an open access journal, which allows authors to fund their article to be open access from publication.